Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|June 9, 2016
Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for MalariaAllison M Stickles, Martin J Smilkstein, Joanne M Morrisey, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 10, 2024
Long-acting intramuscular injections of ELQ-331, an antimalarial agentDipu Karunakaran, Shravan K Mutyam, Melody Fu, et al.
Nature Structural & Molecular Biology|May 19, 2025
Structure, assembly and inhibition of the Toxoplasma gondii respiratory chain supercomplexAndrew E MacLean, Shikha Shikha, Mariana Ferreira Silva, et al.
Organic Process Research & Development|February 3, 2022
A New Scalable Synthesis of ELQ-300, ELQ-316, and other Antiparasitic QuinolonesSovitj Pou, Rozalia A Dodean, Lisa Frueh, et al.
The Journal of Infectious Diseases|May 5, 2022
Babesia duncani as a Model Organism to Study the Development, Virulence, and Drug Susceptibility of Intraerythrocytic Parasites In Vitro and In VivoAnasuya C Pal, Isaline Renard, Pallavi Singh, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2021
Effective Therapy Targeting Cytochrome <i>bc</i><sub>1</sub> Prevents <i>Babesia</i> Erythrocytic Development and Protects from Lethal InfectionJoy E Chiu, Isaline Renard, Anasuya C Pal, et al.
ACS Infectious Diseases|September 15, 2016
Diphenylether-Modified 1,2-Diamines with Improved Drug Properties for Development against Mycobacterium tuberculosisMarie H Foss, Sovitj Pou, Patrick M Davidson, et al.
The American Journal of Tropical Medicine and Hygiene|April 29, 2015
Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapyAllison M Stickles, Li-Min Ting, Joanne M Morrisey, et al.
Malaria Journal|August 29, 2019
ELQ-331 as a prototype for extremely durable chemoprotection against malariaMartin J Smilkstein, Sovitj Pou, Alina Krollenbrock, et al.
ACS Infectious Diseases|September 21, 2017
Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of MalariaLisa Frueh, Yuexin Li, Michael W Mather, et al.
Pageof 4